In our study, treatment with WEPT resulted in a significant downregulation of elevated IL-6, IL-1β and TNF-α levels in the lung tissue, as well as IL-6, IL-1β and TNF-α in the serum of COPD mice, thereby providing evidence for its therapeutic potential in modulating inflammatory responses. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.